167 evolution "https:" "https:" "https:" "https:" "https:" "https:" "BioData" positions at Zintellect
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
to cross international boundaries and present a risk to U.S. livestock. The fellow will have the opportunity to contribute to the development of novel insecticides targeting arthropod pests of livestock
-
Organization U.S. Food and Drug Administration (FDA) Reference Code FDA-CDER-2026-0056 How to Apply To submit your application, scroll to the bottom of this opportunity and click APPLY. A complete application consists of: An application Transcripts – Click here for detailed information about...
-
of oncologic agents under development, providing unique insights into the patient experience of symptomatic adverse events that traditional clinical assessments may miss. Our published proof-of-concept study
-
interests with areas of research need to OSE (e.g., drug safety, substance use disorders, pharmacovigilance, pharmacoepidemiology methods development). You will have learning opportunities that include
-
, pharmacoepidemiology methods development). Through this fellowship, you will have opportunities to learn: Understanding of pharmacovigilance workflows; GenAI based algorithm and agent development for causality
-
interests with areas of research need to OSE (e.g., drug safety, substance use disorders, pharmacovigilance, pharmacoepidemiology methods development). You will have learning opportunities that include
-
, pharmacovigilance, pharmacoepidemiology methods development). In general you will have opportunities to learn: Understanding of pharmacovigilance workflows; GenAI based algorithm and agent development for causality
-
scientists. You will have the opportunity to align your interests with areas of research need to OSE (e.g., drug safety, substance use disorders, pharmacovigilance, pharmacoepidemiology methods development
-
literature and no clinical pharmacology guidance exists due to their novelty and rapid evolution. The research aims to facilitate product development, assist review decision-making, identify regulatory
-
one drug development such as a diagnosis biomarker for patient enrollment at the early stage and later drug treatment effect assessment as pharmacodynamic effect to support the drug effectiveness as a